The Highly Sensitized Patients: Effects of Mycophenolate Mofetil On Anti-HLA Antibody Levels In Patients Awaiting Cadaveric Renal Transplant.

Trial Profile

The Highly Sensitized Patients: Effects of Mycophenolate Mofetil On Anti-HLA Antibody Levels In Patients Awaiting Cadaveric Renal Transplant.

Completed
Phase of Trial: Phase II

Latest Information Update: 12 Jun 2015

At a glance

  • Drugs Mycophenolate mofetil (Primary)
  • Indications Renal transplant rejection
  • Focus Therapeutic Use
  • Acronyms HICAD-MMF
  • Most Recent Events

    • 06 Apr 2010 Actual patient number (45) added as reported by ClinicalTrials.gov.
    • 10 Oct 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top